1218250

Octapharma AB — FEI 3005559915

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 19, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Stockholm (Sweden)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified
358321 CFR 211.110(a)Written in-process control procedures